Literature DB >> 8011572

Efficacy of amlodipine besilate therapy for variant angina: evaluation by 24-hour Holter monitoring.

K Watanabe1, T Izumi, Y Miyakita, S Koyama, M Ohshima, T Inomata, M Suzuki, M Takahashi, A Shibata.   

Abstract

The efficacy of amlodipine, a calcium antagonist, was investigated in 12 patients with variant angina. Amlodipine was administered at a dose of 5 mg once daily, and efficacy was assessed from the frequency of anginal attacks, the frequency of ST elevation or depression, and the extent of ST segment changes [ST segment elevation or depression (mm) x duration (seconds)] on the Holter ECG before and after treatment. The frequency of ST elevation during the observation period was 1.67 +/- 0.33 times/day (symptomatic attacks: 1.17 +/- 0.21/day; asymptomatic attacks: 0.50 +/- 0.19/day), and this significantly decreased to zero per day (both symptomatic and asymptomatic attacks) after treatment (p < 0.05). The extent of ST segment elevation during the observation period was 507.5 +/- 156.6 mm.sec/day (symptomatic: 382.5 +/- 102.9 mm.sec/day; asymptomatic: 125.0 +/- 62.0 mm.sec/day), and such changes were completely suppressed (both symptomatic and asymptomatic) by treatment (p < 0.05). The frequency of ST depression was 2.08 +/- 0.42 times/day (symptomatic: 0.25 +/- 0.13/day; asymptomatic: 1.83 +/- 0.37/day) during the observation period, while it was 1.50 +/- 0.36 times/day (symptomatic: 0.25 +/- 0.13/day; asymptomatic: 1.25 +/- 0.30/day) after treatment. Although anginal attacks remained unchanged, asymptomatic attacks tended to decrease (p = 0.07).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8011572     DOI: 10.1007/bf00877728

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  10 in total

1.  Amlodipine versus nadolol in patients with stable angina pectoris.

Authors:  S Singh; J Doherty; V Udhoji; K Smith; J Gorwit; S Bekheit; S Mather; W Stein; J San Fellippo; P Hearan
Journal:  Am Heart J       Date:  1989-11       Impact factor: 4.749

2.  A four-week double-blind, placebo-controlled, parallel dose-response study of amlodipine in patients with stable exertional angina pectoris.

Authors:  S H Taylor; P Lee; N Jackson; G Cocco
Journal:  Am Heart J       Date:  1989-11       Impact factor: 4.749

3.  Efficacy and safety of amlodipine in vasospastic angina: an interim report of a multicenter, placebo-controlled trial. The Investigators of Study 160.

Authors:  R A Chahine; R L Feldman; T D Giles; A E Raizner; R J Weiss; P Nicod
Journal:  Am Heart J       Date:  1989-11       Impact factor: 4.749

Review 4.  The efficacy of amlodipine in myocardial ischemia.

Authors:  S H Taylor
Journal:  Am Heart J       Date:  1989-11       Impact factor: 4.749

5.  Long-term prognosis for patients with variant angina and influential factors.

Authors:  H Yasue; A Takizawa; M Nagao; S Nishida; M Horie; J Kubota; S Omote; K Takaoka; K Okumura
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

6.  Amlodipine pretreatment and the ischemic heart.

Authors:  W G Nayler
Journal:  Am J Cardiol       Date:  1989-11-07       Impact factor: 2.778

7.  Cardioprotective effects of amlodipine in the ischemic-reperfused heart.

Authors:  P T Hoff; Y Tamura; B R Lucchesi
Journal:  Am J Cardiol       Date:  1989-11-07       Impact factor: 2.778

Review 8.  Pharmacologic profile of amlodipine.

Authors:  R A Burges; M G Dodd; D G Gardiner
Journal:  Am J Cardiol       Date:  1989-11-07       Impact factor: 2.778

9.  Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.

Authors:  E Kimura; H Kishida
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

10.  Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.

Authors:  S P Glasser; T W West
Journal:  Am J Cardiol       Date:  1988-09-15       Impact factor: 2.778

  10 in total
  2 in total

Review 1.  Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.

Authors:  M Haria; A J Wagstaff
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 2.  Coronary artery spasm: Current knowledge and residual uncertainties.

Authors:  Massimo Slavich; Riyaz Suleman Patel
Journal:  Int J Cardiol Heart Vasc       Date:  2016-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.